Overview
- 144 inspections across 133 sites are on record.
- 590 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-24.
At a glance
Inspections
144
Sites
133
Observations
590
Career since
Sep 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Oxalis Labs | 24 Apr 2026 | Human Drugs | View 483 → |
| Cipla Limited | 17 Apr 2026 | Human Drugs | On file |
| Apotek Production & Laboratorier AB | 29 Jan 2026 | Human Drugs | On file |
| Charles River Laboratories, Inc. | 20 Jan 2026 | Human Drugs | |
| Sato Pharmaceutical Co., Ltd. | 21 Nov 2025 | Human Drugs | On file |
Sites inspected
Oxalis LabsSolan, India1 insp.
Cipla LimitedSalcette, India1 insp.
Apotek Production & Laboratorier ABUmea, Sweden1 insp.
Charles River Laboratories, Inc.Malvern, United States1 insp.
Sato Pharmaceutical Co., Ltd.Hachioji, Japan1 insp.
Co-investigators
Investigators who share inspections with this person.
Justin A Boyd6 shared
Kristen E Szenderski5 shared
Gayle S Lawson5 shared
Christina K Theodorou4 shared
Jose E Melendez4 shared
Ko U Min4 shared
Linda F Murphy4 shared
Samina S Khan4 shared
Michael L Casner4 shared
Jeffrey P Raimondi3 shared
Full investigator report
Get the verbatim findings behind Anastasia M Shields' 590 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site